DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Lavigne-Lissalde G, Aya AG, Mercier FJ. et al.
Recombinant human FVIIa for reducing the need for invasive second-line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trial.
J Thromb Haemost 2015;
13: 520-529
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.